Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts

Brain Research

Volumn 742, Issue 1-2, 1996, Pages 253-259

  Rowland, Neil E ^a   Morien, Annie ^a   Fregly, Melvin J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

AT 1 receptor antagonist; EXP 3174; hypovolemia; isoproterenol; lamina terminalis; magnocellular hypothalamic nuclei; polyethylene glycol

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DRUG METABOLITE; ISOPRENALINE; LOSARTAN; MACROGOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUID INTAKE; HYPOTENSION; HYPOVOLEMIA; IMMUNOCYTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUBFORNICAL ORGAN; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; IMIDAZOLES; LOSARTAN; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 0030566720     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01016-5     Document Type: Article

References (39)

1. Badoer E., McKinley M.J., Oldfield B.J., McAllen R.M. A comparison of hypotensive and non-hypotensive hemorrhage on Fos expression in spinally projecting neurons of the paraventricular nucleus and rostral ventrolateral medulla. Brain Res. 610:1993;216-223.
2. Barbella Y., Cierco M., Israel A. Effect of losartan, a nonpeptide angiotensin II receptor antagonist, on drinking behavior and renal actions of centrally administered renin. Proc. Soc. Exp. Biol. Med. 202:1993;401-406.
3. Bui J.D., Kimura B., Phillips M.I. Losartan potassium, a nonpeptide antagonist of angiotensin II chronically administered p.o. does not readily cross the blood brain barrier. Eur. J. Pharmacol. 219:1992;147-151.
4. Evered M.D. Investigating the role of angiotensin II in thirst: interactions between arterial pressure and the control of drinking. Can. J. Physiol. Pharmacol. 70:1992;791-797.
5. Evered M.D., Robinson M.M., Rose P.A. Effect of arterial pressure on drinking and urinary responses to angiotensin II. Am. J. Physiol. 254:1988;R69-R74.
6. Fregly M.J., Rowland N.E. Do peripheral and cerebro-ventricular injections of angiotensin II act at the same site? Studies on the additivity of drinking. Brain Res. Bull. 16:1986;249-257.
7. Fregly M.J., Rowland N.E. Effect of a nonpeptide angiotensin II receptor antagonist, DuP753, on angiotensin-related water intake in rats. Brain Res. Bull. 27:1991;97-100.
8. Fregly M.J., Rowland N.E. Effect of DuP 753, a nonpeptide angiotensin II receptor antagonist, on the drinking responses to acutely administered dipsogenic agents in rats. Proc. Soc. Exp. Biol. Med. 199:1992;158-164.
9. Gardiner S.M., Bennett T. Pressor contributions from angiotensin and vasopressin after polyethylene glycol. Am. J. Physiol. 251:1988;R769-R774.
10. Gorbea-Oppliger V.J., Fink G.D. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II. J. Pharmacol. Exp. Ther. 273:1995;611-616.
11. Graham J.C., Hoffman G.E., Sved A.F. c-Fos expression in brain in response to hypotension and hypertension in conscious rats. J. Auton. Nerv. Syst. 55:1995;92-104.
12. Herbert J., Forsling M.J., Howes S.R., Stacey P.M., Shiers H.M. Regional expression of c-fos antigen in the basal forebrain following intraventricular infusions of angiotensin and its modulation by drinking either water or saline. Neuroscience. 51:1992;867-882.
13. Iyer S.N., Wright B.E., Strubbe G., Hanley K., Katovich M.J. Chronic losartan treatment blocks isoproterenol-induced dispogenesis. Physiol. Behav. 58:1995;283-286.
14. Johnson A.K., Cunningham J.T., Thunhorst R.L. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin. Exp. Pharmacol. Physiol. 23:1996;183-191.
15. Krukoff T.L., MacTavish D., Harris K.H., Jhamandas J.H. Changes in blood volume and pressure induce c-fos expression in brainstem neurons that project to the paraventricular nucleus of the hypothalamus. Mol. Brain Res. 34:1995;99-108.
16. Lenkei Z., Corvol P., Llorens-Cortes C. The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control. Mol. Brain Res. 30:1995;53-60.
17. Li Z., Bains J.S., Ferguson A.V. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Res. Bull. 30:1993;33-39.
18. Mann J.F.E., Johnson A.K., Ganten D. Plasma angiotensin II: dipsogenic levels and angiotensin-generating capacity of renin. Am. J. Physiol. 238:1980;R372-R377.
19. McKinley M.J., Badoer E., Vivas L., Oldfield B.J. Comparison of c-fos expression in the lamina terminalis of conscious rats after intravenous or intracerebroventricular angiotensin. Brain Res. Bull. 37:1995;131-137.
20. McKinley M.J., McAllen R.M., Mendelsohn F.A.O., Allen A.M., Chai S.Y., Oldfield B.J. Circumventricular organs: neuroendocrine interfaces between the brain and hemal milieu. Front. Neuroendocrinol. 11:1990;91-127.
21. Oldfield B.J., McKinley M.J. Distribution of Fos in rat brain resulting from endogenously-generated angiotensin II. Kidney Intl. 46:1994;1567-1569.
22. Palmer A.A., Steele M.K., Shackelford R.L., Ganong W.F. Intravenous losartan inhibits the increase in plasma luteinizing hormone and water intake produced by intraventricular angiotensin II. Proc. Soc. Exp. Biol. Med. 205:1994;263-266.
23. Phillips M.I., Balhorn L., Leavitt M., Hoffman W.E. Scanning electron morcoscope study of the rat subfornical organ. Brain Res. 80:1974;95-110.
24. 1 receptor antagonists to cross the blood-brain barrier in rats. Eur. J. Pharmacol. 307:1996;259-267.
25. Rowe B.P., Saylor D.L., Speth R.C. Analysis of angiotensin II receptor subtypes in individual rat brain nuclei. Neuroendocrinology. 55:1992;563-573.
26. Rowland N.E., Fregly M.J. Effect of nonpeptide angiotensin AT-1 and AT-2 antagonists on isoproterenol-induced renin release. Pharmacol. Biochem. Behav. 44:1993;623-626.
27. Rowland, N.E. and Fregly, M.J., Role of angiotensin in the dispogenic effect of bradykinin in rats, Pharmacol. Biochem. Behav., in press.
28. Rowland, N.E., Fregly, M.J., Li, B.-H. and Han, L., Angiotensin-related induction of immediate early genes in rat brain, Regul. Pept., in press.
29. Rowland N.E., Fregly M.J., Li B.-H., Smith G.C. Action of angiotensin converting enzyme inhibitors in rat brain: interaction with isoproterenol assessed by fos immunocytochemistry. Brain Res. 654:1994;34-40.
30. Rowland N.E., Li B.-H., Rozelle A.K., Fregly M.J., Garcea M., Smith G.C. Localization of changes in immediate early genes in brain in relation to hydromineral balance: intravenous angiotensin II. Brain Res. Bull. 33:1994;427-436.
31. Rowland N.E., Li B.-H., Rozelle A.K., Smith G.C. Comparison of fos-like immunoreactivity induced in rat brain by central injection of angiotensin peptides and carbachol. Am. J. Physiol. 267:1994;R792-R798.
32. Rowland N.E., Rozelle A., Riley P.J., Fregly M.J. Effect of nonpeptide angiotensin receptor antagonists on water intake and salt appetite in rats. Brain Res. Bull. 29:1992;389-393.
33. Smith D.W., Day T.A. Hypovolaemic and osmotic stimuli induce distinct patterns of c-fos expression in the rat subfornical organ. Brain Res. 698:1995;232-236.
34. Song K., Zhuo J., Mendelsohn F.A.O. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors. Br. J. Pharmacol. 104:1991;769-770.
35. Stricker E.M. Thirst and sodium appetite after colloid treatment in rats: role of the renin-angiotensin-aldosterone system. Behav. Neurosci. 97:1983;725-737.
36. Van Eekelen J.A.M., Phillips M.I. Plasma angiotensin II levels at the moment of drinking during angiotensin II intravenous infusion. Am. J. Physiol. 255:1988;R500-R506.
37. Widdop R.E., Gardiner S.M., Bennett T. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats. Brain Res. 648:1994;46-52.
38. Wong P.C., Price W.A., Chiu A.T., Duncia J.V., Carini D.J., Wexler R.R., Johnson A.L., Timmermans P.B.M.W.M. In vivo pharmacology of DuP 753. Am. J. Hypertens. 4:1991;288S-298S.
39. 1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro auto-radiography. Clin. Exp. Pharmacol. Physiol. 21:1994;557-567.